Clinical Trial: Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)

U.S., Aug. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07767253) titled 'Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)' on Aug. 07.

Brief Summary: This study is a 2-part (parts A and B) study.The primary objective of the study is to evaluate the efficacy of 611 in Chinese Children with moderate to severe atopic dermatitis (AD).

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Dermatitis, Atopic

Intervention: DRUG: 611

Solution for injection, subcutaneous (SC)

DRUG: 611

Solution for injection, subcutaneous (SC)

DRUG: Matching placebo

Solution for injection, subcutaneous (SC)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sunshine Guoji...